Aarhus University Hospital Skejby
Clinical trials sponsored by Aarhus University Hospital Skejby, explained in plain language.
-
New device may reduce bruising after heart artery procedure
Disease control CompletedThis study tested whether a device called FemoSeal is safer and more comfortable than standard manual pressure for closing the femoral artery after coronary angiography. About 1005 adults who had heart imaging through a groin artery took part. The main goal was to see if the devi…
Phase: PHASE4 • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated May 26, 2026 05:37 UTC
-
Heart stent study: which branch strategy wins?
Disease control CompletedThis study looked at the best way to use drug-eluting stents (small mesh tubes) to open blocked heart arteries that have a side branch. It compared stenting both the main artery and the side branch versus stenting only the main artery and treating the side branch if needed. The t…
Phase: PHASE4 • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated May 26, 2026 05:34 UTC
-
Heart valve showdown: which TAVI device wins?
Disease control CompletedThis study compared two types of artificial heart valves (Sapien and Myval) used in a procedure called TAVI to replace a narrowed aortic valve. Over 1,000 patients were randomly assigned to receive one of the two valves. The main goal was to see which valve led to fewer major hea…
Phase: NA • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
Heart stent showdown: which technique wins?
Disease control CompletedThis study compared two ways of placing stents (small mesh tubes) to open blocked heart arteries at a fork (bifurcation). 425 patients with chest pain took part. The goal was to see which method—crush or culotte—led to fewer heart problems like heart attack or repeat procedures.…
Phase: PHASE4 • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Dissolving stent shows promise for tricky heart blockages
Disease control CompletedThis study tested a new type of stent made from magnesium that slowly dissolves over time. The stent releases a drug to prevent artery re-narrowing and was used in 20 patients with heart disease and complex blockages. The goal was to see if the stent is safe and works well in the…
Phase: NA • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Heart patients get best of both worlds in hybrid procedure
Disease control CompletedThis study looked at a 'hybrid' approach for people with severe coronary artery disease, combining bypass surgery with stenting. Researchers wanted to see if this mix could reduce deaths, strokes, and heart attacks better than using either method alone. The study enrolled 2000 pa…
Phase: NA • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated May 18, 2026 12:02 UTC